Event Details

Investor conference call discussing interim results from the Phase 1/2 clinical trial (PQ-110-001) of QR-110 in LCA10 patients

Sep 5, 2018 at 8:15 AM EDT   through  
Title
Investor conference call discussing interim results from the Phase 1/2 clinical trial (PQ-110-001) of QR-110 in LCA10 patients
Date / Time
Sep 5, 2018 at 8:15 AM EDT
Description

Conference call participants:

·       Daniel de Boer, Founder and CEO

·       Smital Shah, CFO

·       David Rodman, Executive Vice President of R&D

 

Webcast link & dial-in details:

Webcast link

+1-877-407-3982 or +1-201-493-6780 (international)

Conference ID: 13682382